DermatologyResearch Phase

Myristoyl Pentapeptide-17

Topical

Overview

Myristoyl Pentapeptide-17 is a lipopeptide composed of a pentapeptide sequence conjugated to myristic acid to facilitate penetration of the hair follicle and dermal layers. It is marketed primarily for enhancement of eyelash and eyebrow growth through proposed stimulation of keratin gene expression and prolongation of the anagen phase of the hair cycle.

Mechanism of Action

The peptide is intended for cosmetic applications related to hair conditioning and growth..

Research Summary & Key Findings

Preclinical keratinocyte culture studies have suggested increased keratin synthesis, and small consumer studies have reported subjective improvements in eyelash length and thickness. No randomized, placebo-controlled trials have been published in peer-reviewed ophthalmology or dermatology journals, and the peptide lacks regulatory approval for hair growth indications.

Clinical Status

Research Phase

Myristoyl Pentapeptide-17 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Myristoyl Pentapeptide-17 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Myristoyl Pentapeptide-17.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.